ARA-290 Nasal Spray

£24.99£44.98

ARA-290 is a version of erythropoietin that reduces inflammatory pathways through paracrine signalling and natural repair receptors. Studies show that ARA-290 lowers HbA1c, improves cholesterol, controls neuropathic pain and peripheral neuropathies, and speeds up the healing of wounds.

ARA290 15ml contains: 2mg
ARA290 30ml contains: 4mg

Buy 10 and get 10% Discount
- +

498 in stock

Description

BUY ARA-290 NASAL PEPTIDE SPRAY

This product is intended for research and medical purposes only, to be only used by trained professionals.

ARA-290 nasal is a short peptide generated from the beta-helix of erythropoietin (EPO). It has been known for some time that EPO has other effects besides boosting the generation of red blood cells in the bone marrow.

In diabetic neuropathy, glycoprotein, a kidney-produced protein, has been demonstrated to improve cell survival, stimulate the growth of blood vessels, and modify blood pressure.

As an EPO neuroprotectant and analgesic, ARA-290 does not enhance red blood cell formation.

According to studies, ARA-290 could be tested. In addition, the peptide’s ability to alleviate neuropathic pain is currently being studied.

It is also being investigated as a potential wound-healing stimulant, immunological modulator, and systemic lupus erythematosus (SLE) therapy.

REFERENCES:

1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883966/
2. https://molmed.biomedcentral.com/articles/10.2119/molmed.2012.00332

Molecular Formula: C51H84N16O21
Sequence: XEQLERALNSS
Storage: Lyophilized peptides stored below -18°C.

Research use only. Not for human or animal consumption!

Disclaimer: We do not supply peptides to Any individual under the age of 18. You must be a licensed and qualified healthcare practitioner. Our team of dedicated professionals are committed to providing an extensive range of products used ONLY FOR medical research by responsible trained and professional individuals. All products listed on this website (https://direct-peptides.com) and provided through Direct Peptides are intended for medical research purposes only. Direct Peptides does not encourage or promote the use of any of these products in a personal capacity (i.e. human consumption), nor are the products intended as a drug, stimulant or for use in any food products